IP Library Granted Patent US 7,419,823
Granted Patent B2
US 7,419,823 · App. 10/688,904 · Granted Sep 2, 2008

Device and method for monitoring leukocyte migration

Assignee: Surface Logix, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,419,823
App. No.
10/688,904
Granted
Sep 2, 2008
Kind
B2
Abstract

A device for monitoring leukocyte migration is provided. The invention also provides a method of using the device to monitor leukocyte migration in the presence of physiological shear flow and therefore simulate physiological conditions of a blood vessel in vivo. The invention further provides a method of using the device to high-throughput screen a plurality of test agents. The present invention further provides a flexible assay system and numerous assays that can be used to test biological interactions and systems. Laminar flow gradients are employed that mimic gradient situations present in vivo.

Claims (27)

1. A system for monitoring leukocyte migration comprising:

a device including a housing having a base member and a top member defining a plurality of chambers therein, each of the plurality of chambers including:

a first well region including at least one first well;

a second well region including at least one second well; and

a channel region including at least one channel connecting the first well region and the second well region with one another,

wherein the at least one channel is formed as a through-hole in the top member;

a first fluid stream having a first concentration of a first substance; and

a second fluid stream having a second concentration of a second substance,

wherein the first and second concentrations are different from one another and the first and second fluid streams are in fluid communication with at least one of the plurality of chambers, and

wherein the first fluid stream and the second fluid stream flow adjacent and parallel to each other without mixing, to create a dynamic concentration gradient.

2. The system of claim 1 , wherein the first and second substance are the same.

3. The system of claim 1 , wherein the first and second substance are different.

4. The system of claim 1 , wherein the first fluid stream and the second fluid stream converge into a single third fluid stream that is in fluid communication with the at least one of the plurality of chambers, wherein the third fluid stream comprises a concentration gradient of the first and second substances, the concentration gradient being substantially perpendicular to the direction of flow of the third fluid stream.

5. The system of claim 1 , wherein the first and second fluid streams converge into a single third stream, then diverge into three separate fourth, fifth, and sixth streams, and then re-converge into a single seventh stream, the seventh stream in fluid communication with the at least one of the plurality of chambers under conditions of substantially laminar flow.

6. The system of claim 1 , wherein at least one of the first and second substance is a cytokine.

7. The system of claim 6 , wherein the cytokine is tumor necrosis TNF-α.

8. The system of claim 1 , wherein at least one of the first and second substance is a test agent.

9. A method of monitoring leukocyte migration comprising:

providing a device including a housing having a base member and a top member defining a plurality of chambers therein, each of the plurality of chambers including:

a first well region including at least one first well;

a second well region including at least one second well; and

a channel region including at least one channel connecting the first well region and the second well region with one another, wherein the at least one channel is formed as a through-hole in the top member;

disposing at least one leukocyte migration mediator, or endothelial cells in the at least one channel;

delivering a sample comprising leukocytes to the at least one channel by laminar flow; and

observing the interaction between the leukocytes and the at least one leukocyte migration mediator or the interaction between the leukocytes and the endothelial cells.

10. The method of claim 9 , further comprising providing a video camera operatively linked to the device for viewing the at least one channel.

11. The method of claim 10 , wherein the video camera is adapted to capture an image during predetermined intervals over a predetermined period of time.

Assignments (4)
ENTITY CONVERSION Recorded Sep 17, 2025
From: SURFACE LOGIX, INC.
To: SURFACE LOGIX LLC
Reel/Frame 072915/0828 →
SECURITY AGREEMENT Recorded Nov 29, 2010
From: SURFACE LOGIX, INC.
To: SILICON VALLEY BANK
Reel/Frame 025406/0642 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF THE FOURTH ASSIGNEE'S NAME PREVIOUSLY RECORDED ON REEL 015183 FRAME 0946. Recorded Oct 12, 2004
From: KIRK, GREGORY L.; OSTUNI, EMANUELE; KIM, ENOCH; SCHUELLER, OLIVIER; SWEETNAM, PAUL
To: SURFACE LOGIX
Reel/Frame 015237/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2004
From: KIRK, GREGORY L.; OSTUNI, EMANUELE; KIM, ENOCH; SCHEULLER, OLIVIER; SWEETNAM, PAUL
To: SURFACE LOGIX
Reel/Frame 015183/0946 →
Continuity (12)
Continuation In Part 1024144500 · Sep 12, 2002
Continuation In Part 1009732900 · Mar 15, 2002
Continuation In Part 1009735100 · Mar 15, 2002
Continuation In Part 1009730600 · Mar 15, 2002
Continuation In Part 1009730400 · Mar 15, 2002
Continuation In Part 1009732200 · Mar 15, 2002
Continuation In Part 1009730200 · Mar 15, 2002
Continuation In Part 0970977600 · Nov 8, 2000
Continuation In Part 1020611200 · Jul 29, 2002
Provisional Application 6041998000 · Oct 22, 2002
Provisional Application 6041997600 · Oct 22, 2002
Related Publication 20040142408A1 · Jul 22, 2004